Magellan Financial Group Limited (ASX:MFG)

Ligand Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	188.54	322.57	373.45	419.92	211.58	437.51
Cash & Short-Term Investments	188.54	322.57	373.45	419.92	211.58	437.51
Cash Growth	-42.20%	-13.62%	-11.07%	98.47%	-51.64%	120.76%
Accounts Receivable	-	54.7	53.45	64.3	114	126.83
Other Receivables	-	1.07	1.19	0.35	0.13	0.38
Receivables	50.1	58.78	58.27	66.27	118.39	136.43
Prepaid Expenses	1.73	0.99	0.98	0.99	1.34	0.78
Other Current Assets	3.24	2.57	2.96	2.37	2.47	2.4
Total Current Assets	243.6	384.9	435.65	489.56	333.78	577.12
Property, Plant & Equipment	5.15	5.89	7.93	10.15	12.12	14.25
Long-Term Investments	728.77	564.78	570.23	541.73	689.65	396.42
Goodwill	-	106.15	106.25	105.29	102.84	105.25
Other Intangible Assets	108.99	1.14	2.53	6	10.22	15.3
Long-Term Deferred Tax Assets	-	-	45.84	49.85	41.11	-
Other Long-Term Assets	2.08	3.28	4.06	6.92	5.26	1.97
Total Assets	1,107	1,089	1,199	1,241	1,216	1,124
Accounts Payable	10.14	9.49	9.93	13.46	10.33	10.09
Accrued Expenses	19.31	32.62	37.7	33.42	28.21	25.72
Current Portion of Leases	2.95	2.78	2.61	2.59	2.28	2.41
Current Income Taxes Payable	17.46	8.83	12.77	18.48	11.58	20.18
Other Current Liabilities	-	-	159.86	133.35	157.55	0.31
Total Current Liabilities	49.85	53.72	222.86	201.3	209.93	58.71
Long-Term Leases	3.62	4.83	7.56	9.97	12.33	14.88
Long-Term Deferred Tax Liabilities	14.88	7.75	-	-	-	1.25
Other Long-Term Liabilities	2.52	3.41	6.05	3.38	4.47	3.11
Total Liabilities	70.87	69.72	236.47	214.64	226.73	77.95
Common Stock	609.91	627.73	632.87	671.72	607.85	525.27
Retained Earnings	408.89	379.41	320.52	350.52	381.69	517.27
Comprehensive Income & Other	16.95	12.38	9.12	4.53	-0.1	3.38
Shareholders' Equity	1,036	1,020	962.5	1,027	989.43	1,046
Total Liabilities & Equity	1,107	1,089	1,199	1,241	1,216	1,124
Total Debt	6.57	7.61	10.17	12.55	14.6	17.29
Net Cash (Debt)	181.97	314.96	363.27	407.37	196.98	420.23
Net Cash Growth	-42.66%	-13.30%	-10.82%	106.81%	-53.13%	112.03%
Net Cash Per Share	1.01	1.74	1.99	2.20	1.07	2.32
Filing Date Shares Outstanding	179.11	180.75	181.43	185.09	183.79	182.28
Total Common Shares Outstanding	179.11	180.75	181.43	185.09	183.79	182.28
Working Capital	193.75	331.18	212.79	288.26	123.84	518.41
Book Value Per Share	5.78	5.64	5.31	5.55	5.38	5.74
Tangible Book Value	926.75	912.24	853.72	915.47	876.37	925.38
Tangible Book Value Per Share	5.17	5.05	4.71	4.95	4.77	5.08

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.